1-14 of 14
Glenn J. Bubley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Rana R. McKay, Lucia Kwak, Jett P. Crowdis, Jamie M. Sperger, Shuang G. Zhao, Wanling Xie, Lillian Werner, Rosina T. Lis, Zhenwei Zhang, Xiao X. Wei, Joshua M. Lang, Eliezer M. Van Allen, Rupal S. Bhatt, Evan Y. Yu, Peter S. Nelson, Glenn J. Bubley, R. Bruce Montgomery, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3610–3619.
https://doi.org/10.1158/1078-0432.CCR-20-4616
Published: 01 July 2021
View articletitled, Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Open the PDF for Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance in another window
Includes: Supplementary data
Journal Articles

Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial

Channing J. Paller, Xian C. Zhou, Elisabeth I. Heath, Mary-Ellen Taplin, Tina Mayer, Mark N. Stein, Glenn J. Bubley, Roberto Pili, Tamaro Hudson, Radhika Kakarla, Muneer M. Abbas, Nicole M. Anders, Donna Dowling, Serina King, Ashley B. Bruns, William D. Wagner, Charles G. Drake, Emmanuel S. Antonarakis, Mario A. Eisenberger, Samuel R. Denmeade, Michelle A. Rudek, Gary L. Rosner, Michael A. Carducci
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2): 306–315.
https://doi.org/10.1158/1078-0432.CCR-17-1100
Published: 15 January 2018
View articletitled, Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
Open the PDF for Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Carla Calagua, Joshua Russo, Yue Sun, Rachel Schaefer, Rosina Lis, Zhenwei Zhang, Kathleen Mahoney, Glenn J. Bubley, Massimo Loda, Mary-Ellen Taplin, Steven P. Balk, Huihui Ye
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (22): 6812–6822.
https://doi.org/10.1158/1078-0432.CCR-17-0807
Published: 14 November 2017
View articletitled, Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
Open the PDF for Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide in another window
Includes: Supplementary data
Journal Articles

Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4

Adam G. Sowalsky, Haydn T. Kissick, Sean J. Gerrin, Rachel J. Schaefer, Zheng Xia, Joshua W. Russo, M. Simo Arredouani, Glenn J. Bubley, Martin G. Sanda, Wei Li, Huihui Ye, Steven P. Balk
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3823–3833.
https://doi.org/10.1158/1078-0432.CCR-16-2414
Published: 13 July 2017
View articletitled, Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4
Open the PDF for Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4 in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Enzalutamide Prior to Prostatectomy

Bruce Montgomery, Maria S. Tretiakova, Anthony M. Joshua, Martin E. Gleave, Neil Fleshner, Glenn J. Bubley, Elahe A. Mostaghel, Kim N. Chi, Daniel W. Lin, Martin Sanda, William Novotny, Kenneth Wu, Philip W. Kantoff, Brett T. Marck, Stephen Plymate, Steven P. Balk, Peter S. Nelson, Alvin M. Matsumoto, Rosina T. Lis, Adam Kibel, Gabriel P. Haas, Andrew Krivoshik, Alison Hannah, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (9): 2169–2176.
https://doi.org/10.1158/1078-0432.CCR-16-1357
Published: 30 April 2017
View articletitled, Neoadjuvant Enzalutamide Prior to Prostatectomy
Open the PDF for Neoadjuvant Enzalutamide Prior to Prostatectomy in another window
Includes: Supplementary data
Journal Articles

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer

Rana R. McKay, Lillian Werner, Elahe A. Mostaghel, Rosina Lis, Olga Voznesensky, Zhenwei Zhang, Brett T. Marck, Alvin M. Matsumoto, Liran Domachevsky, Katherine A. Zukotynski, Manoj Bhasin, Glenn J. Bubley, Bruce Montgomery, Philip W. Kantoff, Steven P. Balk, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (4): 935–945.
https://doi.org/10.1158/1078-0432.CCR-16-0987
Published: 14 February 2017
View articletitled, A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer
Open the PDF for A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors

Eddy J. Chen, Adam G. Sowalsky, Shuai Gao, Changmeng Cai, Olga Voznesensky, Rachel Schaefer, Massimo Loda, Lawrence D. True, Huihui Ye, Patricia Troncoso, Rosina L. Lis, Philip W. Kantoff, Robert B. Montgomery, Peter S. Nelson, Glenn J. Bubley, Steven P. Balk, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (6): 1273–1280.
https://doi.org/10.1158/1078-0432.CCR-14-1220
Published: 12 March 2015
View articletitled, Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors
Open the PDF for Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response

Charles J. Ryan, Shreya Shah, Eleni Efstathiou, Matthew R. Smith, Mary-Ellen Taplin, Glenn J. Bubley, Christopher J. Logothetis, Thian Kheoh, Christine Kilian, Christopher M. Haqq, Arturo Molina, Eric J. Small
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (14): 4854–4861.
https://doi.org/10.1158/1078-0432.CCR-11-0815
Published: 17 July 2011
View articletitled, Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response
Open the PDF for Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response in another window
Journal Articles

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Mary-Ellen Taplin, Meredith M. Regan, Yoo-Joung Ko, Glenn J. Bubley, Stephen E. Duggan, Lillian Werner, Tomasz M. Beer, Christopher W. Ryan, Paul Mathew, Shi-Ming Tu, Samuel R. Denmeade, William K. Oh, Oliver Sartor, Christos S. Mantzoros, Roger Rittmaster, Philip W. Kantoff, Steven P. Balk
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7099–7105.
https://doi.org/10.1158/1078-0432.CCR-09-1722
Published: 11 November 2009
View articletitled, Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
Open the PDF for Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer in another window
Journal Articles

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

Mohamed S. Arredouani, Bin Lu, Manoj Bhasin, Miriam Eljanne, Wen Yue, Juan-Miguel Mosquera, Glenn J. Bubley, Vivian Li, Mark A. Rubin, Towia A. Libermann, Martin G. Sanda
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5794–5802.
https://doi.org/10.1158/1078-0432.CCR-09-0911
Published: 14 September 2009
View articletitled, Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Open the PDF for Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

The Challenge of Herbal Therapies for Prostate Cancer

Rupal S. Bhatt, Glenn J. Bubley
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7581–7582.
https://doi.org/10.1158/1078-0432.CCR-08-2316
Published: 01 December 2008
View articletitled, The Challenge of Herbal Therapies for Prostate Cancer
Open the PDF for The Challenge of Herbal Therapies for Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Minimal Effect of a Low-Fat/High Soy Diet for Asymptomatic, Hormonally Naive Prostate Cancer Patients

Dimitrios Spentzos, Christos Mantzoros, Meredith M. Regan, Mary Ellen Morrissey, Stephen Duggan, Stacy Flickner-Garvey, Heather McCormick, William DeWolf, Steve Balk, Glenn J. Bubley
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3282–3287.
Published: 05 September 2003
View articletitled, Minimal Effect of a Low-Fat/High Soy Diet for Asymptomatic, Hormonally Naive Prostate Cancer Patients
Open the PDF for Minimal Effect of a Low-Fat/High Soy Diet for Asymptomatic, Hormonally Naive Prostate Cancer Patients in another window
Journal Articles

A Multi-Institutional Phase II Study of SU101, a Platelet-derived Growth Factor Receptor Inhibitor, for Patients with Hormone-Refractory Prostate Cancer

Yoo-Joung Ko, Eric J. Small, Fairooz Kabbinavar, Abraham Chachoua, Samir Taneja, David Reese, Ann DePaoli, Alison Hannah, Steven P. Balk, Glenn J. Bubley
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 800–805.
Published: 01 April 2001
View articletitled, A Multi-Institutional Phase II Study of SU101, a Platelet-derived Growth Factor Receptor Inhibitor, for Patients with Hormone-Refractory Prostate Cancer
Open the PDF for A Multi-Institutional Phase II Study of SU101, a Platelet-derived Growth Factor Receptor Inhibitor, for Patients with Hormone-Refractory Prostate Cancer in another window
Journal Articles

A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer

Joseph Paul Eder, Philip W. Kantoff, Kristin Roper, GuangXian Xu, Glenn J. Bubley, John Boyden, Linda Gritz, Gail Mazzara, William K. Oh, Philip Arlen, Kwong Y. Tsang, Dennis Panicali, Jeffrey Schlom, Donald W. Kufe
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1632–1638.
Published: 01 May 2000
View articletitled, A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer
Open the PDF for A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer in another window